InsiderClue
← All stocks

Starling Oncology, Inc.

STLN Scheduled selling only
CIK 0001799191 #2884 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$1.95M
$1.95M on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 1 sales
Net
−$1.95M
$0.00 against sales at will

By person

17 insiders · 1 transaction
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hively Brad
Director
—
$1.95M (1) scheduled
−$1.95M
411,976
0.4042%
$2.68M
−45.2%
Chernett Jorey
10% owner
—
—
—
10,660,858
10.46%
$69.43M
+8.0%
M33 Growth I L.P.
Director
—
—
—
5,444,207
5.34%
$35.46M
−64.3%
BARASCH RICHARD A
Director
—
—
—
4,571,022
4.49%
$29.77M
+101.2%
Virnich Daniel
Chief Executive Officer
—
—
—
2,337,166
2.29%
$15.22M
+3.5%
Carter Robert Ross
Chief Financial Officer
—
—
—
649,975
0.6378%
$4.23M
−3.4%
Pacala Mark L
Director
—
—
—
511,852
0.5022%
$3.33M
+42.2%
Ling Gabriel
Director
—
—
—
333,539
0.3273%
$2.17M
+383.0%
McGeorge Anne
Director
—
—
—
332,535
0.3263%
$2.17M
+161.1%
Johnson Karen Marie
Director
—
—
—
319,410
0.3134%
$2.08M
+177.3%
Podnos Yale
Chief Medical Officer
—
—
—
259,527
0.2546%
$1.69M
+148.7%
Castle Jeremy
Chief Operating Officer
—
—
—
247,031
0.2424%
$1.61M
+199.6%
Kaushal Mohit
Director
—
—
—
205,716
0.2018%
$1.34M
+69.7%
England Kristin
Chief Administrative Officer
—
—
—
153,780
0.1509%
$1.00M
—
Langsam Jeffrey
Chief Clinical Officer
—
—
—
127,650
0.1253%
$831.33K
—
STOLPER MARK
Director
—
—
—
56,957
0.0559%
$370.94K
—
TZOUMAKAS KIMBERLY JO
Director
—
—
—
46,301
0.0454%
$301.54K
—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 17 Mar 2020